Udemy

Empowering Policy: Precision Healthcare in EU

Explore genomics, oncology, rare diseases, ERNs
Free tutorial
Rating: 5.0 out of 5 (3 ratings)
337 students
2hr of on-demand video
English
English [Auto]

Understand Precision Medicine Evolution: Learn transition from histology to agnostic models, guiding targeted cancer therapies.
Master key technologies such as next-generation sequencing and liquid biopsy in precision oncology.
Navigate regulatory frameworks and challenges in rare disease care within the EU.
Understand the transition in oncology towards precision medicine, including genomic profiling and targeted therapies.
Explore Global Precision Oncology: Address racial disparities, foster collaboration for equitable access.

Requirements

  • Basic understanding of healthcare concepts and terminology.
  • Interest in personalized medicine and its impact on healthcare policy and practice.
  • A foundational understanding of biology, particularly in the context of genetics and cancer biology, will aid in comprehending the intricacies of precision healthcare discussed in the course.

Description

"Empowering Policy: Precision Healthcare in the EU" is a comprehensive course that explores personalized medicine and healthcare policy within the European Union. Tailored for healthcare professionals, policymakers, and all personalized medicine enthusiasts, this course navigates through the complexities of personalized medicine, examining its evolution, challenges, and potential.

Led by expert instructors, the course commences with an overview of the European Alliance for Personalised Medicine (EAPM), emphasizing its pivotal role in shaping personalized healthcare policies. Participants will analyze barriers impeding the widespread adoption of personalized medicine in Europe and scrutinize the intersection of healthcare policy with cancer survivorship.

Subsequent sections delve into genomics and emerging trends in oncology, tracing the evolution of precision oncology and addressing challenges and innovations in genomic oncology. Learners will explore global precision oncology initiatives and contemplate the future trajectory of personalized medicine.

The course also provides insights into technological advancements such as Liquid Biopsy and Next-Generation Sequencing (NGS), elucidating key principles in genomic medicine and clinical ctDNA testing.

As the course progresses, participants will examine the value of personalized medicine across disease areas and the patient journey. Topics include initiatives like the 1+ Million Genomes Initiative, advancements in rare disease care, and the integration of European Reference Networks (ERNs) into national healthcare systems.

Through lectures, quizzes, and case studies, participants will gain a thorough understanding of personalized medicine's potential and the policy frameworks required to implement it effectively across Europe's healthcare landscape.

Enroll in this course to gain insight into precision healthcare policy in the EU and contribute to the advancement of personalized medicine in practice.

This course, the first of five interconnected modules, serves as a foundational exploration into precision healthcare policy within the EU, with subsequent courses delving into global perspectives, as well as specialized topics such as breast, lung, prostate, colorectal cancer, hematology, rare diseases, hereditary cancers, and more. We invite every student to enroll in our comprehensive series to broaden their understanding and expertise in the evolving landscape of personalized medicine.

Who this course is for:

  • Healthcare Administrators and Policy Makers: Professionals involved in healthcare policy development, implementation, and decision-making within the EU seeking insights into the regulatory frameworks and initiatives shaping precision healthcare.
  • Oncologists and Cancer Researchers: Professionals seeking to enhance their understanding of precision oncology, genomic profiling, and targeted therapies in cancer care.
  • Rare Disease Specialists: Healthcare professionals focusing on rare diseases within the EU who wish to navigate the complexities of diagnosis, treatment, and collaborative initiatives.
  • Biomedical Scientists and Geneticists: Individuals interested in genomic medicine, next-generation sequencing, liquid biopsy technologies, and their applications in precision healthcare.
  • Students and Enthusiasts: Those pursuing education or research in healthcare, genetics, or related fields, as well as individuals with a general interest in precision medicine.

Instructor

Healthcare Policy Expert
  • 4.4 Instructor Rating
  • 21 Reviews
  • 816 Students
  • 4 Courses

Prof. Denis Horgan, a distinguished leader in policy and governmental affairs, brings over 15 years of experience in driving transformative change in healthcare systems. As the former Director of the European Cancer Patient Coalition and Executive Director of the European Alliance of Personalised Medicine, Prof. Horgan has spearheaded numerous initiatives to advance the adoption of personalized healthcare across the EU. With a robust background in academia, including the publication of over 50 academic articles, Prof. Horgan is a renowned expert in the field of personalized medicine. His passion for innovation and commitment to improving healthcare outcomes make him a dynamic and influential figure in the global healthcare community.

Top companies trust Udemy

Get your team access to Udemy's top 30,000+ courses